RYTM - Rhythm Pharmaceuticals, Inc. -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
Rhythm Pharmaceuticals, Inc.
Rhythm Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders.
IPO Date: October 5, 2017
Sector: Healthcare
Industry: Biotech
Market Cap: $6.09B
Activated in VL: True
Average Daily Range
Avg Daily Range: $1.01 | 3.02%
Avg Daily Range (30 D): $1.60 | 1.61%
Avg Daily Range (90 D): $2.10 | 2.05%
Institutional Daily Volume
Avg Daily Volume: .43M
Avg Daily Volume (30 D): .51M
Avg Daily Volume (90 D): .58M
Trade Size
Avg Trade Size (Sh.): 66
Avg Trade Size (Sh.) (30 D): 44
Avg Trade Size (Sh.) (90 D): 48
Institutional Trades
Total Institutional Trades: 3,996
Avg Institutional Trade: $2.81M
Avg Institutional Trade (30 D): $4.51M
Avg Institutional Trade (90 D): $4.06M
Avg Institutional Trade Volume: .06M
Avg Institutional Trades (Per Day): 2
Market Closing Trades
Avg Closing Trade: $4.72M
Avg Closing Trade (30 D): $9.95M
Avg Closing Trade (90 D): $11.68M
Avg Closing Volume: 102.49K
 
News
Aug 4, 2026 @ 10:55 AM
Rhythm Pharmaceuticals Announces Preliminary Data ...
Source: Na
Jul 17, 2026 @ 1:16 AM
Kuehn Law Encourages Investors of Rhythm Pharmaceu...
Source: Kuehn Law, Pllc
Jun 15, 2026 @ 4:51 PM
Why Is Rhythm Pharma Stock Jumping Today?
Source: Vandana Singh
May 29, 2026 @ 12:00 PM
Rhythm Pharmaceuticals Announces Seven Abstracts A...
Source: Na
May 26, 2026 @ 12:00 PM
Rhythm Pharmaceuticals Announces Participation in ...
Source: Rhythm Pharmaceuticals, Inc.
Financials
  TTM Q1 2026 Q4 2025
Basic EPS $-.73 $-.83 $-.73
Diluted EPS $-.73 $-.83 $-.73
Revenue $71.26M $60.11M $57.25M
Gross Profit $62.32M $52.96M $52.45M
Net Income / Loss $-49.3M $-55.64M $-47.51M
Operating Income / Loss $-48.55M $-52.36M $-47.06M
Cost of Revenue $8.93M $7.16M $4.8M
Net Cash Flow $3.7M $7.47M $2.01M
PE Ratio